Bumrungrad International Hospital, a private multiple-specialty medical centre founded 1980 in Bangkok, Thailand, announced the launch of FoundationOne CDx, the first broad companion diagnostic assay to be endorsed by the USFDA in 2017.
from News from healthcareitnews.com http://bit.ly/2Lc3Jvr
via IFTTT
Monday, April 29, 2019
Home »
News from healthcareitnews.com
» Bumrungrad International launches comprehensive genomic profiling for cancer treatment
0 comments:
Post a Comment